Page last updated: 2024-09-03

gefitinib and Injury, Myocardial Reperfusion

gefitinib has been researched along with Injury, Myocardial Reperfusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Elenius, K; Heliste, J; Jokilammi, A; Paatero, I; Vaparanta, K	1

Other Studies

1 other study(ies) available for gefitinib and Injury, Myocardial Reperfusion

Article	Year
Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia. Scientific reports, 2021, 08-17, Volume: 11, Issue:1 Topics: Animals; Cardiotonic Agents; Cell Hypoxia; Cell Line; Disease Models, Animal; Drug Discovery; ErbB Receptors; Gefitinib; Hypoxia; Mice; Myocardial Reperfusion Injury; Myocytes, Cardiac; Protein Kinase Inhibitors; Zebrafish	2021

Article

Year

Combined genetic and chemical screens indicate protective potential for EGFR inhibition to cardiomyocytes under hypoxia.

Scientific reports, 2021, 08-17, Volume: 11, Issue:1

Topics: Animals; Cardiotonic Agents; Cell Hypoxia; Cell Line; Disease Models, Animal; Drug Discovery; ErbB Receptors; Gefitinib; Hypoxia; Mice; Myocardial Reperfusion Injury; Myocytes, Cardiac; Protein Kinase Inhibitors; Zebrafish

2021